Kenneth Trofatter, Jr

Title: Innovations by Kenneth Trofatter, Jr.

Introduction

Kenneth Trofatter, Jr. is an accomplished inventor based in Minnetonka, MN (US). He has made significant contributions to the field of medical technology, particularly in the treatment of conditions associated with mucosal surfaces. His innovative approach has led to the development of a unique system that addresses important health issues.

Latest Patents

Kenneth Trofatter, Jr. holds a patent for "Systems and methods for treating a mucosal surface." This patent describes a system designed to treat conditions related to mucosal surfaces, utilizing an immune response modifier (IRM) compound. The IRM compounds include various chemical structures such as imidazoquinoline amines and oxazoloquinoline amines, among others. The system also features an applicator device that allows for the precise application of the IRM compound to the mucosal surface. This innovative system can be used to treat conditions such as cervical dysplasia and cervical intraepithelial neoplasia.

Career Highlights

Kenneth Trofatter, Jr. is associated with 3M Innovative Properties Company, where he has been able to leverage his expertise in developing groundbreaking medical solutions. His work has not only advanced the field but has also contributed to the overall improvement of patient care.

Collaborations

Throughout his career, Kenneth has collaborated with notable colleagues, including John C. Hedenstrom and Michael J. Jozwiakowski. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Kenneth Trofatter, Jr. exemplifies the spirit of innovation in the medical technology field. His contributions, particularly in the treatment of mucosal surface conditions, highlight the importance of research and development in improving health outcomes. His work continues to inspire future advancements in medical treatments.